Amalia Cipollone

Title: Amalia Cipollone: Innovator in Pharmaceutical Synthesis

Introduction

Amalia Cipollone is a distinguished inventor based in Rome, Italy. She has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of processes for the preparation of important medications. With a total of 5 patents to her name, her work has had a notable impact on the industry.

Latest Patents

Cipollone's latest patents include innovative processes for the synthesis of Nebivolol, a medication used to treat high blood pressure. The first patent describes a novel process characterized by a reduced number of high-yield steps, which includes the enzymatic resolution of the chroman ester precursor. The second patent also focuses on the synthesis of Nebivolol, emphasizing the kinetic resolution of diastereoisomeric epoxide pairs, which allows for the avoidance of complex chromatographic separations.

Career Highlights

Throughout her career, Amalia Cipollone has worked with prominent companies in the pharmaceutical sector. Notably, she has been associated with Menarini International Operations Luxembourg S.a. and Menarini Ricerche S.p.a. Her expertise in pharmaceutical synthesis has been instrumental in advancing the development of effective medications.

Collaborations

Cipollone has collaborated with several talented professionals in her field, including Daniela Fattori and Sandra Bartoli. These collaborations have further enriched her research and contributed to her success as an inventor.

Conclusion

Amalia Cipollone's innovative work in pharmaceutical synthesis, particularly her contributions to the development of Nebivolol, showcases her expertise and dedication to advancing medical science. Her patents reflect a commitment to improving drug synthesis processes, which can lead to more effective treatments for patients.